Recombinant Lactococcus lactis Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced Model

Type 1 diabetes (T1D) is an autoimmune disease that culminates in beta cell destruction in the pancreas and, subsequently, deficiency in insulin production. Cytokines play a crucial role in the development of diabetes, orchestrating the recruitment and action of immune cells, to not only destroy ins...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatiane M. Preisser, Vanessa P. da Cunha, Mariana P. Santana, Vanessa B. Pereira, Denise C. Cara, Bianca M. Souza, Anderson Miyoshi
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2021/6697319
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550996342996992
author Tatiane M. Preisser
Vanessa P. da Cunha
Mariana P. Santana
Vanessa B. Pereira
Denise C. Cara
Bianca M. Souza
Anderson Miyoshi
author_facet Tatiane M. Preisser
Vanessa P. da Cunha
Mariana P. Santana
Vanessa B. Pereira
Denise C. Cara
Bianca M. Souza
Anderson Miyoshi
author_sort Tatiane M. Preisser
collection DOAJ
description Type 1 diabetes (T1D) is an autoimmune disease that culminates in beta cell destruction in the pancreas and, subsequently, deficiency in insulin production. Cytokines play a crucial role in the development of diabetes, orchestrating the recruitment and action of immune cells, to not only destroy insulin-producing cells but also preserve them. Therefore, the aim of this study was to investigate the effect of orally administered Lactococcus lactis MG1363 FnBPA+ strains carrying plasmids encoding IL-4 and IL-10 in the streptozotocin- (STZ-) induced diabetes model and in nonobese diabetic (NOD) mice. The STZ-induced mice that were treated with combined bacterial strains carrying plasmids encoding IL-4 and IL-10 showed lower incidence of diabetes and more preserved pancreatic islets than the mice that received the individual bacterial strains. Combined administration of L. lactis MG1363 FnBPA+ (pValac::dts::IL-4) and L. lactis MG1363 FnBPA+ (pValac::IL-10) resulted in protection against diabetes in NOD mice. It was shown that the combined treatment with recombinant bacterial by oral route prevented hyperglycemia and reduced the pancreatic islets-destruction in NOD mice. In addition, increased levels of IL-4 and IL-10 in serum and pancreatic tissue revealed a systemic effect of the treatment and also favored an anti-inflammatory microenvironment. Reduced concentrations of IL-12 in pancreas were essential to the regulation of inflammation, resulting in no incidence of diabetes in treated NOD mice. Normal levels of intestinal sIgA after long-term treatment with the L. lactis strains carrying plasmids encoding IL-4 and IL-10 indicate the development of oral tolerance and corroborate the use of this potent tool of mucosal delivery. For the first time, L. lactis MG1363 FnBPA+ strains carrying eukaryotic expression vectors encoding IL-4 and IL-10 are tested in STZ-induced and NOD mouse models. Therefore, our study demonstrates this innovative strategy provides immunomodulatory potential for further investigations in T1D and other autoimmune diseases.
format Article
id doaj-art-a48e0351cf0f4344b717c5a92b13d897
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-a48e0351cf0f4344b717c5a92b13d8972025-02-03T06:05:17ZengWileyJournal of Diabetes Research2314-67452314-67532021-01-01202110.1155/2021/66973196697319Recombinant Lactococcus lactis Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced ModelTatiane M. Preisser0Vanessa P. da Cunha1Mariana P. Santana2Vanessa B. Pereira3Denise C. Cara4Bianca M. Souza5Anderson Miyoshi6Laboratory of Genetic Technology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais ZIP/Post Code: 31270-901, BrazilLaboratory of Genetic Technology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais ZIP/Post Code: 31270-901, BrazilLaboratory of Genetic Technology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais ZIP/Post Code: 31270-901, BrazilLaboratory of Genetic Technology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais ZIP/Post Code: 31270-901, BrazilCenter for Gastrointestinal Biology, Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais ZIP/Post Code: 31270-901, BrazilLaboratory of Genetic Technology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais ZIP/Post Code: 31270-901, BrazilLaboratory of Genetic Technology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais ZIP/Post Code: 31270-901, BrazilType 1 diabetes (T1D) is an autoimmune disease that culminates in beta cell destruction in the pancreas and, subsequently, deficiency in insulin production. Cytokines play a crucial role in the development of diabetes, orchestrating the recruitment and action of immune cells, to not only destroy insulin-producing cells but also preserve them. Therefore, the aim of this study was to investigate the effect of orally administered Lactococcus lactis MG1363 FnBPA+ strains carrying plasmids encoding IL-4 and IL-10 in the streptozotocin- (STZ-) induced diabetes model and in nonobese diabetic (NOD) mice. The STZ-induced mice that were treated with combined bacterial strains carrying plasmids encoding IL-4 and IL-10 showed lower incidence of diabetes and more preserved pancreatic islets than the mice that received the individual bacterial strains. Combined administration of L. lactis MG1363 FnBPA+ (pValac::dts::IL-4) and L. lactis MG1363 FnBPA+ (pValac::IL-10) resulted in protection against diabetes in NOD mice. It was shown that the combined treatment with recombinant bacterial by oral route prevented hyperglycemia and reduced the pancreatic islets-destruction in NOD mice. In addition, increased levels of IL-4 and IL-10 in serum and pancreatic tissue revealed a systemic effect of the treatment and also favored an anti-inflammatory microenvironment. Reduced concentrations of IL-12 in pancreas were essential to the regulation of inflammation, resulting in no incidence of diabetes in treated NOD mice. Normal levels of intestinal sIgA after long-term treatment with the L. lactis strains carrying plasmids encoding IL-4 and IL-10 indicate the development of oral tolerance and corroborate the use of this potent tool of mucosal delivery. For the first time, L. lactis MG1363 FnBPA+ strains carrying eukaryotic expression vectors encoding IL-4 and IL-10 are tested in STZ-induced and NOD mouse models. Therefore, our study demonstrates this innovative strategy provides immunomodulatory potential for further investigations in T1D and other autoimmune diseases.http://dx.doi.org/10.1155/2021/6697319
spellingShingle Tatiane M. Preisser
Vanessa P. da Cunha
Mariana P. Santana
Vanessa B. Pereira
Denise C. Cara
Bianca M. Souza
Anderson Miyoshi
Recombinant Lactococcus lactis Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced Model
Journal of Diabetes Research
title Recombinant Lactococcus lactis Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced Model
title_full Recombinant Lactococcus lactis Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced Model
title_fullStr Recombinant Lactococcus lactis Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced Model
title_full_unstemmed Recombinant Lactococcus lactis Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced Model
title_short Recombinant Lactococcus lactis Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced Model
title_sort recombinant lactococcus lactis carrying il 4 and il 10 coding vectors protects against type 1 diabetes in nod mice and attenuates insulitis in the stz induced model
url http://dx.doi.org/10.1155/2021/6697319
work_keys_str_mv AT tatianempreisser recombinantlactococcuslactiscarryingil4andil10codingvectorsprotectsagainsttype1diabetesinnodmiceandattenuatesinsulitisinthestzinducedmodel
AT vanessapdacunha recombinantlactococcuslactiscarryingil4andil10codingvectorsprotectsagainsttype1diabetesinnodmiceandattenuatesinsulitisinthestzinducedmodel
AT marianapsantana recombinantlactococcuslactiscarryingil4andil10codingvectorsprotectsagainsttype1diabetesinnodmiceandattenuatesinsulitisinthestzinducedmodel
AT vanessabpereira recombinantlactococcuslactiscarryingil4andil10codingvectorsprotectsagainsttype1diabetesinnodmiceandattenuatesinsulitisinthestzinducedmodel
AT deniseccara recombinantlactococcuslactiscarryingil4andil10codingvectorsprotectsagainsttype1diabetesinnodmiceandattenuatesinsulitisinthestzinducedmodel
AT biancamsouza recombinantlactococcuslactiscarryingil4andil10codingvectorsprotectsagainsttype1diabetesinnodmiceandattenuatesinsulitisinthestzinducedmodel
AT andersonmiyoshi recombinantlactococcuslactiscarryingil4andil10codingvectorsprotectsagainsttype1diabetesinnodmiceandattenuatesinsulitisinthestzinducedmodel